Acute Lymphoblastic Leukemia Therapeutics Market: Industry Analysis and Forecast (2018-2026)
Acute lymphoblastic leukemia (ALL) is a cancer of bone marrow and blood that is caused due to uncontrolled generation of lymphoblast, which are immature white blood cells (WBCs). Renal failure, pneumonia, respiratory distress, and bone pain are some of the common symptoms of ALL. The progression rate is high in ALL and the condition may lead to death within few months, if left untreated. Lymphoblast malfunction and accumulate around healthy cells. In ALL, the bone marrow loses the ability to...
View full press release